Company
Merz
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
8
510(k), De Novo and PMA
Device trials
38
As lead sponsor, any status
Adverse event reports
172
Received Nov 1, 2025 to Nov 20, 2026
Recall records
8
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Merz, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Merz.
Latest FDA decisions
P250016 · Decided Jul 9, 2026 · 387 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
P250020 · Decided May 19, 2026 · 327 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- RADIESSE® Injectable ImplantPMA supplement
P050052-S162 · Decided Mar 31, 2026 · 678 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
5 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and NeckPivotal-lookingActive, not recruiting
NCT07614997 · 218 participants · Start Jun 15, 2026 · Primary completion Dec 2026
Device: Ulthera System · For: Cutis Laxa
Sites: Beijing, China; Guangzhou, China; Nanjing, China · 7 sites in all
NCT07856797 · 163 participants (planned) · Start Oct 27, 2026 · Primary completion Aug 2027
Device: Subdermal Implant · For: Nasolabial Folds
Sites: Beijing, China; Changde, China; Chengdu, China · 8 sites in all
NCT06093815 · 20 participants · Start Sep 8, 2023 · Primary completion May 1, 2024
Device: Injection · For: Injection Site Reaction
Sites: Marbella, Spain
35 more trials with a free account
Reports received
172
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
2
1.2% of reports
Injury reports
170
99% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 9 | 0 | 1 |
| Jan 24 | 0 | 12 | 0 | 0 |
| Feb 24 | 0 | 17 | 0 | 0 |
| Mar 24 | 0 | 17 | 0 | 0 |
| Apr 24 | 0 | 3 | 0 | 0 |
| May 24 | 0 | 6 | 0 | 0 |
| Jun 24 | 0 | 12 | 0 | 0 |
| Jul 24 | 0 | 13 | 0 | 0 |
| Aug 24 | 0 | 7 | 0 | 0 |
| Sep 24 | 0 | 9 | 0 | 0 |
| Oct 24 | 0 | 6 | 0 | 0 |
| Nov 24 | 0 | 7 | 0 | 0 |
| Dec 24 | 0 | 14 | 0 | 0 |
| Jan 25 | 0 | 6 | 0 | 0 |
| Feb 25 | 0 | 4 | 0 | 0 |
| Mar 25 | 0 | 16 | 0 | 0 |
| Apr 25 | 0 | 6 | 0 | 0 |
| May 25 | 0 | 18 | 0 | 0 |
| Jun 25 | 1 | 10 | 0 | 0 |
| Jul 25 | 0 | 20 | 0 | 0 |
| Aug 25 | 0 | 14 | 0 | 0 |
| Sep 25 | 2 | 3 | 0 | 0 |
| Oct 25 | 0 | 15 | 0 | 0 |
| Nov 25 | 0 | 11 | 0 | 0 |
| Dec 25 | 0 | 17 | 0 | 0 |
| Jan 26 | 0 | 17 | 0 | 0 |
| Feb 26 | 0 | 12 | 0 | 0 |
| Mar 26 | 0 | 9 | 0 | 0 |
| Apr 26 | 0 | 15 | 0 | 0 |
| May 26 | 0 | 12 | 0 | 0 |
| Jun 26 | 1 | 13 | 0 | 0 |
| Jul 26 | 0 | 13 | 0 | 0 |
| Aug 26 | 0 | 20 | 0 | 0 |
| Sep 26 | 1 | 17 | 0 | 0 |
| Oct 26 | 0 | 14 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
2 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- RADIESSE72
5 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0401-2021 · Started Sep 30, 2020
Reason given: The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.
Cause as FDA categorized it: Labeling design · Device type: Agent, Bulking, Injectable For Gastro-Urology Use (LNM)
Z-2607-2016 · Started May 20, 2016 · Posted by FDA Aug 19, 2016
Reason given: Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Implant, Dermal, For Aesthetic Use (LMH)
Z-0366-2016 · Started Oct 26, 2015 · Posted by FDA Dec 3, 2015
Reason given: The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.
Cause as FDA categorized it: Other · Device type: Implant, Dermal, For Aesthetic Use (LMH)
5 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.